|
⚲
|
| Keyboard |
| Summit Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001599298 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001599298] | |
| 10-Q | [0001599298] | |
| 3 | [0001599298] | |
| 4 | [0001599298] | |
| 5 | [0001599298] | |
| 6-K | [0001599298] | |
| 8-K | [0001599298] | |
| D | [0001599298] | |
| SC 13D | [0001599298] | |
| SC 13G | [0001599298] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zanganeh Mahkam | |
| Summit Therapeutics Inc | |
| Duggan Robert W | |
| Soni Manmeet Singh | |
| Anand Bhaskar | |
| Ronaghi Mostafa | |
| Huber Jeff | |
| Booth Robert F | |
| Cesano Alessandra | |
| Xia Yu | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-08 | Grant | 30,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 11,232 | $8.76 | 98,392 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 7,180 | $8.76 | 62,897 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 9,885 | $8.76 | 86,593 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 17,796 | $8.76 | 155,893 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 35,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 11,232 | $8.76 | 98,392 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 3,219 | $8.76 | 28,198 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Buy | 533,617 | $18.74 | 9,999,983 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Grant | 26,680 | $18.74 | 499,983 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Grant | 53,361 | $18.74 | 999,985 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Grant | 266,808 | $18.74 | 4,999,982 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Buy | 26,680 | $18.74 | 499,983 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Grant | 13,980,789 | $18.74 | 261,999,986 |
|
Summit Therapeutics Inc SMMT
Common Stock
|
2025-10-21 | Grant | 266,808 | $18.74 | 4,999,982 |
| showing 20 of 173 most recent transactions | |||||